Commission Delegated Regulation (EU) 2025/1475 of 21 May 2025 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of the drug precursors 4-piperidone and 1-boc-4-piperidone in the list of scheduled substances
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Draft Joint Committee Decision (JCD) under consideration by the EU (EEAS) and the EFTA States (Iceland, Liechtenstein and Norway)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Legal Documents
Commission Delegated Regulation (EU) 2025/1475 of 21 May 2025 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of the drug precursors 4-piperidone and 1-boc-4-piperidone in the list of scheduled substances
Delegierte Verordnung (EU) 2025/1475 der Kommission vom 21. Mai 2025 zur Änderung der Verordnung (EG) Nr. 273/2004 des Europäischen Parlaments und des Rates und der Verordnung (EG) Nr. 111/2005 des Rates betreffend die Aufnahme der Drogenausgangsstoffe 4-Piperidon und 1-Boc-4-piperidon in die Liste der erfassten Stoffe
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.